No ‘Killer’ Drugs In Nigeria, Says NAFDAC
Against the widespread reports in the social media on the sale of ‘kidney-killer’ malaria drugs in Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) has said there are no such drugs in the country.
At a press briefing in Lagos, Acting Director-General, NAFDAC, Dr. Yetunde Oni, aid the agency is committed to correcting the misinformation on the social media and mainstream media about the banned drugs.
According to her, the allegedly banned drugs are oral monotherapies containing single Active Pharmaceutical Ingredients (API) such as Artesunate as contained in Arinate tablet, Amodiaquine contained in Comoquine, Dihydroartemisinin contained in Alaxin tablets and Pyrimethamine contained in Daraprim tablets which are not recommended for the treatment of malaria in Nigeria.
The Acting DG, therefore, urged Nigerians to use the recommended anti-malarial medicine Artemisin Combination Therapies (ACTs) for the treatment of malaria, which is in line with the guidelines according to the WHO and the Nigeria National Anti-malarial Treatment Policy.